Sahlgrenska University Hospital
Gothenburg, 41650, Sweden
NCT Number: NCT03918954
Sensory room is a new method in psychiatric inpatient care for management of anxiety. Since this method for anxiety management is being implemented more and more extensively within the psychiatric care system it is important to study its effect and whether there is any difference between physical and virtual sensory.
In this study, the effect on mental well-being, pulse and blood pressure will be compared before and after each use of a virtual or physically sensory room. How the different methods affect the total care time, use of anxiety medication and results from self-assessment scales to measure depression and anxiety symptoms will also be looked at. The study will be conducted on two separate wards which primarily care for patients with the primary diagnosis of bipolar disorder.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Gothenburg, 41650, Sweden
This study will include about 100 research subjects admitted to an inpatient ward at the department of psychiatry for affective disorder. The study will be conducted in two inpatient wards. Patients who consent to participation will be offered to stay in a sensory room (a physical sensory room in one ward and a virtual sensory room via a pair of wireless VR glasses in another ward). In connection with the use of the virtual or physical sensory room, the patients will be given a visual analogue scale which asks the patient to rate their overall anxiety and mental health on a scale from 1 (feeling very bad) to 10 (feeling excellent). This will be the primary measure of the study. Before and after each visit the participant will have their pulse and blood pressure measured.
Included patients will also be asked about participation in individual interviews. Semi-structured interviews will be carried out and collected data will be analyzed with a phenomenological approach. The purpose of this study is to shed light on experiences of staying in the digital and analogue sensory rooms.
A number of self-rated questionnaires will be used in the project to establish the research subjects' level of depression and anxiety during their inpatient stay.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A pair of virtual reality glasses (Oculus Go) with installed the program Calm Place, a program designed for anxiety reduction.
A room with calming elements that patients can use to feel calm.
Time frame: Immediately before and following the first administration of treatment
A visual analogue scale from 0 (lowest) to 10 (highest) level of anxiety
Time frame: Once weekly from date of inclusion until the date of discharge up to 3 weeks
Total score on 21 self-rated questions on anxiety (ranging from 0=no anxiety to 63=maximum level of anxiety)
Time frame: Once weekly from date of inclusion until the date of discharge up to 3 weeks
Depression grade on a self-rating scale ranging from 0=no depression to 54=most severe depression
Time frame: Total use of medication from date of inclusion to date of discharge up to 3 weeks
Use in mg of anxiolytic medication
Time frame: Once weekly from date of inclusion until the date of discharge up to 3 weeks
Clinician assessment of patient´s overall mental state ranging from 0 (no symptoms) to 7 (severe mental illness)
Time frame: Length of admission in days from date of inclusion to date of discharge up to a year
Number of days admitted to inpatient care
Time frame: Immediately before and following first administration of treatment
mmHg before and after intervention
Time frame: Immediately before and following first administration of treatment
Heartbeats per minute before and after intervention
Time frame: An average of each immediate before and following measure of the administration of treatment
A visual analogue scale from 0 (lowest) to 10 (highest) level of anxiety
Vastra Gotaland Region
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03485274
Anxiety Disorders, Anxiety State
Hong Kong
View Trial DetailsNCT04924634
Anxiety Disorders, Anxiety State
Opole, Poland
View Trial DetailsNCT04728503
Anxiety Disorders, Anxiety State
Dallas, Texas, United States
View Trial DetailsNCT05956249
Anxiety Disorders, Anxiety State
Porto Alegre, Rio Grande do Sul, Brazil
View Trial Details